Substituted 2-pyrrolinone inhibitors of HIV-1 integrase

被引：27

作者：

Dayam, Raveendra ^{[1
]}

Al-Mawsawi, Laith Q. ^{[1
]}

Neamati, Nouri ^{[1
]}

机构：

[1] Univ So Calif, Sch Pharm, Dept Pharmaceut Sci & Pharmacol, Los Angeles, CA 90089 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2007年 / 17卷 / 22期

关键词：

HIV-1; integrase; beta-diketoacids; pharmacophore; substituted pyrrolin-2-ones; substructure; structure-activity relationship analysis;

D O I：

10.1016/j.bmcl.2007.09.061

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The beta-diketoacid class of HIV-1 integrase (IN) inhibitors represent the first potent class of compounds specific for the strand transfer catalytic activity of the viral enzyme. Previously, utilizing a beta-diketoacid pharmacophore as a search query, we identified a substituted 2-pyrrolinone with modest IN inhibitory activity from a database of small-molecules [Dayam, R.; Sanchez, T.; Neamati, N. J. Med. Chem. 2005, 48, 8009]. In efforts to optimize this class of IN inhibitors, we carried out a structure-activity relationship analysis around the 2-pyrrolinone core. Here, we present a new class of 2-pyrrolinone IN inhibitors. (C) 2007 Elsevier Ltd. All rights reserved.

引用

页码：6155 / 6159

页数：5

共 50 条

[1] 4-Hydroxy-5-pyrrolinone-3-carboxamide HIV-1 integrase inhibitors
Pace, Paola
Spieser, Stephane A. H.
Summa, Vincenzo
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (14) : 3865 - 3869
[2] Multi-Substituted Quinolines as HIV-1 Integrase Allosteric Inhibitors
Long Phi Dinh
Sun, Jian
Glenn, Courtney D.
Patel, Krunal
Pigza, Julie A.
Donahue, Matthew G.
Yet, Larry
Kessl, Jacques J.
VIRUSES-BASEL, 2022, 14 (07):
[3] Resistance to HIV-1 integrase inhibitors: A structural perspective
Mouscadet, Jean-Francois
Delelis, Olivier
Marcelin, Anne-Genevieve
Tchertanov, Luba
DRUG RESISTANCE UPDATES, 2010, 13 (4-5) : 139 - 150
[4] Computational studies of HIV-1 integrase and its inhibitors
Nunthaboot, Nadtanet
Pianwanit, Somsak
Parasuk, Vudhichai
Kokpol, Sirirat
Briggs, James M.
CURRENT COMPUTER-AIDED DRUG DESIGN, 2007, 3 (03) : 160 - 190
[5] Novel furocoumarins as potential HIV-1 integrase inhibitors
Olomola, Temitope O.
Mosebi, Salerwe
Klein, Rosalyn
Traut-Johnstone, Telisha
Coates, Judy
Hewer, Raymond
Kaye, Perry T.
BIOORGANIC CHEMISTRY, 2014, 57 : 1 - 4
[6] N-hydroxy-substituted 2-aryl acetamide analogs: A novel class of HIV-1 integrase inhibitors
Debnath, Utsab
Kumar, Prachi
Agarwal, Aakanksha
Kesharwani, Ajay
Gupta, Satish K.
Katti, Seturam B.
CHEMICAL BIOLOGY & DRUG DESIGN, 2017, 90 (04) : 527 - 534
[7] Clinical progress of HIV-1 integrase inhibitors
Al-Mawsawi, Laith Q.
Al-Safi, Rasha I.
Neamati, Nouri
EXPERT OPINION ON EMERGING DRUGS, 2008, 13 (02) : 213 - 225
[8] HIV-1 Integrase Inhibitors: 2007-2008 Update
Ramkumar, Kavya
Serrao, Erik
Odde, Srinivas
Neamati, Nouri
MEDICINAL RESEARCH REVIEWS, 2010, 30 (06) : 890 - 954
[9] Development of a phenotypic susceptibility assay for HIV-1 integrase inhibitors
Heger, Eva
Theis, Alexandra Andree
Remmel, Klaus
Walter, Hauke
Pironti, Alejandro
Knops, Elena
Di Cristanziano, Veronica
Jensen, Bjoern
Esser, Stefan
Kaiser, Rolf
Luebke, Nadine
JOURNAL OF VIROLOGICAL METHODS, 2016, 238 : 29 - 37
[10] Discovery of small molecule HIV-1 integrase dimerization inhibitors
Tintori, Cristina
Demeulemeester, Jonas
Franchi, Luigi
Massa, Silvio
Debyser, Zeger
Christ, Frauke
Botta, Maurizio
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (09) : 3109 - 3114

← 1 2 3 4 5 →